Colorado § 12-280-305 Restrictions on transactions

Colorado Statutes

§ 12-280-305 — Restrictions on transactions

Colorado § 12-280-305

Title 12Professions

Art.Pharmacists, Pharmacy Businesses,

This text of Colorado § 12-280-305 (Restrictions on transactions) is published on Counsel Stack Legal Research, covering Colorado primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Colo. Rev. Stat. § 12-280-305 (2026).

Text

(1)Repealed.

(2)A manufacturer or wholesaler shall furnish prescription drugs only to a board-registered outlet or practitioner authorized by law to prescribe the drugs. Before furnishing prescription drugs to a person or entity not known to the manufacturer or wholesaler, the manufacturer or wholesaler shall affirmatively verify that the person or entity is legally authorized to receive the prescription drugs by contacting the board.

(3)A manufacturer or wholesaler may furnish prescription drugs to a hospital pharmacy receiving area if a pharmacist or authorized receiving agent signs, at the time of delivery, a receipt showing the type and quantity of the prescription drug received. The pharmacist or authorized receiving agent shall report any discrepancy between the receipt

Free access — add to your briefcase to read the full text and ask questions with AI

(1) Repealed.

(2) A manufacturer or wholesaler shall furnish prescription drugs only to a
board-registered outlet or practitioner authorized by law to prescribe the drugs.
Before furnishing prescription drugs to a person or entity not known to the
manufacturer or wholesaler, the manufacturer or wholesaler shall affirmatively
verify that the person or entity is legally authorized to receive the prescription
drugs by contacting the board.

(3) A manufacturer or wholesaler may furnish prescription drugs to a
hospital pharmacy receiving area if a pharmacist or authorized receiving agent
signs, at the time of delivery, a receipt showing the type and quantity of the
prescription drug received. The pharmacist or authorized receiving agent shall
report any discrepancy between the receipt and the type and quantity of the
prescription drug actually received to the delivering manufacturer or wholesaler by
the next business day after the delivery to the pharmacy receiving area.

(4) Repealed.

Legislative History

Source: L. 2019: Entire title R&RE with relocations, (HB 19-1172), ch. 136, p. 1492, � 1, effective October 1. L. 2021: (1) and (4) repealed, (SB 21-094), ch. 314, p. 1942, � 28, effective September 1.